Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
China capital to roll out tough anti-smoking laws
30 May 2015 at 2:19pm
By Megha Rajagopalan BEIJING (Reuters) - Beijing will ban smoking in restaurants, offices and on public transport from Monday, part of unprecedented new curbs welcomed by anti-tobacco advocates, though how they will be enforced remains to be seen. Health activists have pushed for years for stronger restrictions on smoking in China, the world's largest tobacco consumer, which is considering further anti-smoking curbs nationwide. Under the rules, anyone in China's capital who violates the bans, which include smoking near schools and hospitals, must pay 200 yuan ($32.25).
Apparent Black Widow Spider Found Amongst Michigan Woman's Grapes
30 May 2015 at 1:25pm
Alexis Gentile killed the spider that was making a home within the bunch of grapes she was eating.
Former quadriplegic runs, walks to show others they can
30 May 2015 at 12:35pm
LOS ANGELES (AP) ? The worst day of Aaron Baker's life wasn't when the then-20-year-old professional motocross racer crashed his bike one spring day in 1999, flew over the handlebars and hit the ground head-first, paralyzing him from the neck down.
Pfizer's Ibrance drug slows progression of breast cancer
30 May 2015 at 10:17am
By Deena Beasley CHICAGO (Reuters) - A Phase III trial of Pfizer Inc's Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer. At the time of an interim analysis, patients given Ibrance and AstraZeneca Plc's Faslodex (fulvestrant), a widely used treatment to block estrogen, lived an average of 9.2 months before their cancer worsened. The trial, presented in Chicago at a meeting of the American Society of Clinical Oncology, enrolled 521 patients whose breast cancer was classified as estrogen-receptor positive, human epidermal growth factor receptor 2-negative.
Study sees benefit from more extensive breast cancer surgery
30 May 2015 at 9:54am
CHICAGO (AP) ? Having a little extra tissue taken off during breast cancer surgery greatly lowers the risk that some cancer will be left behind and require a second operation, according to a new study that could change care for more than 100,000 women in the United States alone each year.
New treatments may prolong health after breast cancer
30 May 2015 at 8:59am
Promising advances in research could mean longer, healthier lives for women with breast cancer, the number one cancer in women worldwide, experts said Saturday at a major US cancer conference. A new targeted therapy that appears to double the amount of time cancer can be held in check, a drug that offers more women a chance at healthy lives post-diagnosis and a surgical option to remove extra tissue in order to reduce the likelihood of cancer's return were among the findings presented at the American Society of Clinical Oncology annual meeting in Chicago. The targeted drug, palbociclib, is made by Pfizer and was granted accelerated approval by the US Food and Drug Administration earlier this year for use in women with the most common form of advanced breast cancer, known as estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-).
4 Traps to Avoid When You're Filled With Anxiety
30 May 2015 at 8:57am
When we're slipping on anxiety's slopes, it's usually not pretty.We rant. We rave. We make blanket statements on the condition of our lives.When under pressure, inaccurate self-judgments are likely to creep in. We forget to factor in that we're overworked, tired or just plain depleted. We lose sight that we're resilient, and quite capable of...
Eisai drug extends survival in patients with rare cancers
30 May 2015 at 8:05am
A drug made by Japan's Eisai Co that was originally derived from sea sponges helped extend lives of patients with soft-tissue cancers known as sarcomas by two months, a significant advance for these rare cancers with few treatment options, Belgian researchers said on Saturday. The researchers studied the drug, known as eribulin, in 452 patients with two forms of sarcomas - leiomyosarcoma, which starts in smooth muscles, and adipocytic sarcoma, which starts in fat tissue. "For a disease where such few treatment options exist, a two month improvement in survival is significant," said Dr. Patrick Schoffski, a medical oncologist at University Hospitals Leuven in Belgium, who presented the findings at the American Society of Clinical Oncology meeting on Saturday.
J&J multiple myeloma drug offers hope after others stop working: study
30 May 2015 at 8:03am
An experimental biotech drug being developed by Johnson & Johnson may offer hope to multiple myeloma patients who have run out of options, according to data from a midstage study released at a cancer meeting on Saturday. J&J plans to use the Phase II study to seek U.S. and European approval of its antibody daratumumab to treat the blood cancer. The drug received breakthrough designation from the U.S. Food and Drug Administration, which can help speed the approval process.
New research shows immunotherapy targeting several cancers
30 May 2015 at 7:38am
Immunotherapy, which has shown remarkable success against advanced melanoma skin cancers, is now being used to target other cancers that are tough to treat. The results of several clinical trials were presented on the opening day of the American Society of Clinical Oncology's (ASCO) annual conference in Chicago on Friday. In some cases, immunotherapy has been shown to completely eradicate cancer.
Drug boosts long-term survival after breast cancer: study
30 May 2015 at 7:24am
After a diagnosis of localized breast cancer, women are often prescribed tamoxifen for five years to help prevent a recurrence, but researchers said Saturday another drug, anastrazole, may work better. The federally funded phase III study involved more than 3,100 postmenopausal women with a kind of breast cancer known as ductal carcinoma in situ, which was treated by removing the cancerous lump followed by a radiation regimen. Some women were then randomly assigned to receive tamoxifen and others anastrazole.
U.N. warns of coming hunger in North Korea
30 May 2015 at 2:58am
By Tom Miles GENEVA (Reuters) - A drought in North Korea could lead to huge food shortages this year, the top U.N. official in the country told Reuters in an interview. Rainfall in 2014, the lowest in records going back 30 years, was 40-60 percent below 2013 levels, and reservoirs are very low, said Ghulam Isaczai, the U.N. resident coordinator.
Rights activists protest award for ex-Montana judge who blamed victim of rape
29 May 2015 at 8:07pm
A small group of women's rights activists rallied in Montana on Friday to protest a lifetime achievement award for a state judge censured for suggesting that a 14-year-old girl was partly to blame for her rape by a teacher. More than two dozen protesters led by the Montana chapter of the National Organization for Women attended the candlelight vigil outside the Yellowstone Art Museum in Billings where former state District Judge G. Todd Baugh was to be given the annual award by a local bar association, said Marian Bradley, regional NOW head.
Pentagon: Anthrax shipments broader than first thought
29 May 2015 at 4:07pm
WASHINGTON (AP) ? The Pentagon said Friday that the Army's mistaken shipments of live anthrax to research laboratories were more widespread than it initially reported, prompting the Defense Department's second-ranking official to order a thorough review.
U.S. military orders broad review as anthrax mishap widens
29 May 2015 at 3:39pm
WASHINGTON (Reuters) - The U.S. military said on Friday it discovered even more suspected cases of inadvertent shipments of live anthrax than previously thought, both in the United States and abroad, and ordered a sweeping review of its practices for inactivating samples. "As of now, 24 laboratories in 11 states and two foreign countries are believed to have received suspect samples," the Pentagon said in a statement. (Reporting by Phil Stewart; Editing by Sandra Maler)